Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Why Rite Aid Stock Popped Today

By Jeremy Bowman - Jun 25, 2019 at 5:48PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of the pharmacy chain jumped on renewed hopes for an acquisition.

What happened

Shares of Rite Aid ( RAD -2.75% ) were moving higher on Friday as investor enthusiasm for the stock surged after news of yet another acquisition deal in the healthcare industry, and as the market is anticipating the struggling pharmacy chain's first-quarter earnings report out tomorrow afternoon.

The stock closed up 8.7% after gaining as much as 10.5% earlier in the session.

A pharmacist helping an old man

Image source: Getty Images.

So what 

This morning, AbbVie, the drugmaker best known for Humira, said it would acquire Botox maker Allergan for $63 billion, a move that sent shares of the target company up 25%. AbbVie, on the other hand, plunged 16% as investors seemed to think the company overpaid for Allergan.

Nonetheless, the deal sparked hopes that Rite Aid would find a suitor after a deal with Walgreens Boots Alliance was repeatedly blocked, ending in Rite Aid selling nearly half of its stores to the larger drugstore chain, rather than all of them.

M&A in the healthcare sector has been heating up, with CVS and Aetna merging, and Cigna's acquisition of Express Scripts. After today's news, investors have newfound hope that Rite Aid will be the next to find a dance partner.

Now what 

Shares of the country's No. 3 pharmacy chain have utterly collapsed since the Walgreens deal was blocked, as the stock is down 83% over the last year. Investors even had to endure the ignominy of a 1-for-20 reverse split in April to keep the stock from being delisted by the New York Stock Exchange.

Investors may also be hopeful ahead of the company's first-quarter report coming out after hours tomorrow. Analysts are expecting another round of unremarkable results with an adjusted loss per share of $0.07 and revenue of $5.38 billion, down 0.2% from a year ago, but given its low price and recent volatility, the stock could move sharply again Thursday after the quarterly results come out.

   
This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Rite Aid Corporation Stock Quote
Rite Aid Corporation
RAD
$12.04 (-2.75%) $0.34
Walgreens Boots Alliance, Inc. Stock Quote
Walgreens Boots Alliance, Inc.
WBA
$46.08 (0.39%) $0.18

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
665%
 
S&P 500 Returns
142%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/29/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.